Orthofix Medical Inc (OFIX) USD0.1
$0.25
(1.37%)
- Add to watchlist
- This stock can be held in a
$0.25
(1.37%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
$0.25
(1.37%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Business summary
Orthofix Medical Inc. is a global medical technology company. Its Global Spine segment offers two product categories: Bone Growth Therapies and Spinal Implants, Biologics, and Enabling Technologies. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures. This segment specializes in the design, development, and marketing of external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. Spinal Implants, Biologics, and Enabling Technologies includes a portfolio of spine fixation and motion preservation implant products used in surgical procedures of the spine.
Contact details
Important dates
General stock information
- Short code:
- OFIX
- ISIN:
- US68752M1080
- Market cap:
- $698.56 million
- Shares in issue:
- 38.21 million
- Sector:
- Health Care Equipment
- Exchange:
- NASDAQ
- Country:
- United States
- Currency:
- US dollar
- Indices:
- NASDAQ Comb. Composite
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.